Damian deGoa

Damian deGoa

Chief Executive Officer

Mr. deGoa was CEO of RareGen, LLC, a rare disease commercial company until its merger with Liquidia.  Previously, Mr. deGoa was CEO of Breas Medical Group, a global respiratory medical device company, headquartered in Sweden, until its sale to Fosun Pharma.  Since 2012, Mr. deGoa was a Managing Director/Partner at PBM Capital Group, a healthcare investment firm where he was responsible for M&A and executive leadership at portfolio companies like RareGen and Breas.  Mr. deGoa started his career in the healthcare industry with Perrigo Company holding various roles including corporate development, international business development, and divisional finance lead.

Mr. deGoa holds a BA from the University of Michigan and a MBA from Depaul University.